louisiana semaglutide ban Senate approves weight loss drugs covered by Medicaid Study shows rise in weight

Correcting magnesium deficiency may improve Hashimotos symptoms (24,25)

Wegovy does not require biliary excretion for its metabolismit is broken down by proteolytic enzymes throughout the body, as detailed in the European Medicines Agency's European Public Assessment Report (EPAR)

Cross S, Wei JP, Kim S, Brams DM

Additionally, concurrent medical conditions must be considered

[5] [6] For weight management, NICE technology appraisals (TA664 for semaglutide/Wegovy and TA662 for liraglutide/Saxenda) recommend use only within specialist weight management services for people meeting specific BMI thresholds with weight-related comorbidities